Moore Capital Management »

Entrada Therapeutics shares owned by Moore Capital Management

Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by Moore Capital Management from 13F filings

Historical chart of Moore Capital Management investment in Entrada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Entrada Therapeutics held by Moore Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Entrada Therapeutics by Moore Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $1.5M 105k 14.25
2024-03-31 $1.5M 105k 14.17
2023-12-31 $1.6M 105k 15.09
2023-09-30 $1.7M 105k 15.80
2023-06-30 $1.6M 105k 15.14
2023-03-31 $1.5M 105k 14.50
2022-12-31 $1.4M 105k 13.52
2022-09-30 $1.7M 105k 15.76
2022-06-30 $1.3M 105k 12.18
2022-03-31 $986k 105k 9.39
2021-12-31 $1.8M 105k 17.12